Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2014 Jan;311(4):363-5.
doi: 10.1001/jama.2013.284665.

Will detection of microRNA biomarkers in blood improve the diagnosis and survival of patients with pancreatic cancer?

Donald J Buchsbaum  1 , Carlo M Croce  2
Affiliations
Editorial

Will detection of microRNA biomarkers in blood improve the diagnosis and survival of patients with pancreatic cancer?

Donald J Buchsbaum et al. JAMA. 2014 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.

Comment on

References

    1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30. - PubMed
    1. Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an update. Dig Dis. 2010;28(4–5):645–656. - PubMed
    1. American Cancer Society. [Accessibility verified December 26, 2013];Cancer facts and figures 2013. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/docume....
    1. Oettle H, Neuhaus P, Hochhaus A, et al. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA. 2013;310(14):1473–1481. - PubMed
    1. Conroy T, Desseigne F, Ychou M, et al. Groupe Tumeurs Digestives of Unicancer: PRODIGE Intergroup. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817–1825. - PubMed